Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorobenzene SCHEMBL29118445 | 0.85 | NFE2L2 (0.48) | NFE2L2ALDH1A1TSHRMAPTALOX15 | |
| Fluorobenzene SCHEMBL5606701 | 0.82 | NFE2L2 (0.46) | NFE2L2ALDH1A1TSHRACHEMAPT | |
| Fluorobenzene SCHEMBL22829554 | 0.81 | — | — | |
| Fluorobenzene SCHEMBL15544432 | 0.80 | NFE2L2 (0.53) | NFE2L2ALDH1A1TSHRACHEMAPT | |
| SCHEMBL22526495 | 0.80 | NFE2L2 (0.53) | NFE2L2ALDH1A1TSHRACHEMAPT | |
| Fluorobenzene SCHEMBL14012524 | 0.80 | — | — | |
| Fluorobenzene SCHEMBL12363 | 0.80 | — | — | |
| Fluorobenzene SCHEMBL7024891 | 0.80 | — | — | |
| Fluorobenzene SCHEMBL1891568 | 0.78 | — | — | |
| Fluorobenzene SCHEMBL21829121 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6313139-B1 | ADMINISTERING BENZYLAMINE DERIVATIVE FOR THERAPY OF PSYCHIATRIC DISORDER IN MAMMALS | AKZO NOBEL N. V. (NL) | 2001-11-06 | — | — | US | disclosed |